| Pharmaceutical active ingredients: |
| Pipamperone Hydrochloride |
| Available forms, composition and doses of Dipiperone: |
| Solution; Oral; Pipamperone Hydrochloride 40 mg / mlTablets; Oral; Pipamperone Hydrochloride 40 mg |
| Dipiperone medical category: |
| Human:Antipsychotic drugsButyrophenone derivatives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N05AD05 - Pipamperone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Janssen |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Zypi | Pioglitazone Hydrochloride | Zydus Cadila; RBC-MDC Corporation |
| Dipiperal | Pipamperone | Unidentified Pharmaceutical Company |
| Floropipamide | Pipamperone | Unidentified Pharmaceutical Company |
| Piperonyl | Pipamperone | Unidentified Pharmaceutical Company |
| Dipiperon | Pipamperone Hydrochloride | Janssen |
| Pipamperon | Pipamperone Hydrochloride | Sandoz |
| Piperonil | Pipamperone Hydrochloride | Istituto Luso Farmaco d'Italia |
| Lenopect | Pipazetate | Unidentified Pharmaceutical Company |
| Theratuss | Pipazetate | Unidentified Pharmaceutical Company |
| Selvigon | Pipazetate Hydrochloride | Asta Medica; Sanfer Laboratorios; Sanofi-Aventis; Transfarma Medica Indah; Viatris |